Pantoprazole Sodium Delayed-Release Tablets — Class II drug recall D-1074-2019
Terminated recall by Jubilant Cadista Pharmaceuticals, Inc., reported 2019-04-10, distributed nationwide. Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of
| Recall number | D-1074-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, United States |
| Recall initiated | 2019-03-29 |
| Classified | 2019-04-01 |
| Reported by FDA | 2019-04-10 |
| Terminated | 2019-09-20 |
| Distributed | Nationwide (US) |
| Quantity | 12,960 bottles |
| NDC | 59746-0284-90 |
| Lot numbers | PA217060A |
| Expiration dates | 2020-05 |
Product
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
Reason for recall
Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1074-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.